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SMALL CELL CARCINOMA OF THE BLADDER
Toru Sakatani, Yosuke Shimizu, Yoshio Sugino, Toshinari Yamasaki,
Masaaki Imamura, Yoshiyuki Matsui, Takahiro Inoue, Kazutoshi Okubo,
Tomomi Kamba, Koji Yoshimura and Osamu Ogawa
The Department of Urology, Kyoto University Graduate School of Medicine
We retrospectively reviewed the records of 11 patients with small cell carcinoma of the bladder, who
were diagnosed at Kyoto University Hospital between June 1995 and November 2010. The median age
was 79 years. Two patients had stage I disease, 4 had stage II disease, 2 had stage III disease, and 3 had
stage IV disease. All 3 patients with stage IV disease had metastatic disease. They had very poor prognosis
with a median survival of only 9.1 months (range 3.2-13.0 months). Of 8 patients without metastatic
disease, 3 patients who had been treated with neoadjuvant chemotherapy followed by cystectomy had long-
term survival. The median survival of these 3 patients was 85.5 months (range 38.0-102.8 months), and all
of them are still alive without cancer. The median survival of the other 5 patients was 12.6 months (range 9.
9-33. 8 months). There were significant differences in survival between patients with neoadjuvant
chemotherapy followed by cystectomy and with other treatments (p＝0.024). In conclusion, these results
suggested that neoadjuvant chemotherapy followed by cystectomy could cure patients with small cell
carcinoma of the bladder without metastatic disease.
(Hinyokika Kiyo 60 : 221-225, 2014)














対 象 と 方 法
1995年 6月∼2010年11月の間に膀胱原発小細胞と診
* 現 : 倉敷中央病院泌尿器科
** 現 : 西神戸医療センター泌尿器科
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た．Stage I (T1N0M0），II (T2N0M0），III (T3N0M0），
IV (T4N0M0，TanyN1-3M0，TanyNanyM1) はそれ
ぞれ， 2，4，2，3例であった．Stage IV の 3 例の
TNM 分類は，それぞれ cT3bN2M0，cT4N3M1，
cT4aN0M1と，全例に転移を認めた．
11例の治療成績を局所療法別に Table 2 に示す．局
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Table 1. Characterstics of 11 patients with small
cell bladder carcinoma










Frequency and pain on urination 1
Histology
SmCC only 6
SmCC and UC 3
SmCC, UC and SCC 1




















UC : Urothelial carcinoma, SmCC : Small cell carcinoma,





は 2例が CR を認め，もう 1例は T2 から T1 へ病期
低下を認め，残りの 1例は T1 のまま不変であった．
局所療法として膀胱部分切除術が 2例に施行され，そ







は 3 例で，放射線治療単独の症例が 1 例 (30 Gy/10
回，小骨盤照射），術前補助化学療法を施行した症例
が 1例 (45 Gy/25回，小骨盤照射），動注化学療法を














は，No 1 と No 11 の症例は骨転移に対し緩和的照射
を行い，それぞれ再発 2カ月， 3カ月後に癌死してい
る．No 2 は gemcitabine，paclitaxel 併用療法を 1コー
ス施行するも再発 3カ月後に癌死し，No 3 は cispla-
tin，irinotecan，etoposide 併用療法を追加し多発脳転
移に対し全脳照射 (30 Gy/10 Fr) を施行し再発 6カ月
後に癌死している．また，No 7 の症例は metho-
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Table 2. Treatment and outcome of 11 cases with small cell carcinoma of the bladder







1 87 Male I 100 ― SmCC and UC ― TC Bone DOD(12.6)





3 68 Male IV 3b20 LN SmCC and UC CTx(IrEP○4 ) TC Brain
DOD
(13.0)
4 80 Female II 100 ― SmCC only CTx(ECarbo○4 ) TC ―
NED
(38.0)
5 79 Male II 200 ― SmCC only IACT(EP○1 ) TC ―
NED
(85.5)
6 73 Male III 3b00 ― SmCC only CTx(IrEP○3 ) TC ―
NED
(102.8)
7 58 Male I a00 ― SmCC and UC ― PC Lung, bladder,bone and LN
DOD
(9.9)
8 80 Male III 3b00 ― SmCC only RTx PC ― DOOD(33.8)
9 84 Male IV 431 LN, peritoneumand bone SmCC only
― RTx (30 Gy) Data notavailable
DOD
(3.2)
10 84 Male II 200 ― SmCC, UC,SCC and AC CTx (EP○
4 ) RTx (45 Gy) Data notavailable
AWD
(17.0)
11 76 Male IV 4a01 Lung SmCC only ― IACTx (CE○
1 )
＋RTx (50 Gy) Bone
DOD
(9.1)
UC : Urothelial carcinoma, SmCC : Small cell carcinoma, AC : Adenocarcinoma, SCC : Squamous cell carcinoma, CTx : Chemotherapy,
IACTx : Intra-arterial infusion chemotherapy, IrEP : Irinotecan＋etoposide＋cisplatin, RTx : Radiation therapy, ECarbo : Etoposide＋
cisplatin, TC : Total cystectomy, PC : Partial cystectomy, CE : Cisplatin＋epilubicin, LN : Lymph node, NED : No evidence of disease,
AWD : Alive with disease, DOD : Died of disease, DOOD : Died of other disease.
泌60,05,03-1
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